Our goal is to provide all patients access to testing in a timely manner to ensure efficient diagnosis and disease progression monitoring. PIK3CA Mutation CDx in Tissue or Plasma is a new biomarker-driven strategy for the detection of the PIK3CA mutation and identification of eligible patients for appropriate therapy. FORT MYERS, FL / ACCESSWIRE / May 26, 2020 / NeoGenomics, Inc. (NEO) (the "Company"), a leading provider of cancer-focused genetics testing services, announced today that it has formed a strategic collaboration with Inivata to commercialize the InVisionFirst-Lung liquid biopsy test in the United States. Fort Myers, FL 33913 Just leave your contact information including phone number and availability, and we will respond within two business days. Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support These twelve new tests use cell-free circulating DNA and RNA … NEW YORK – NeoGenomics announced Tuesday a strategic collaboration with liquid biopsy firm Inivata for the commercialization of Inivata's InVisionFirst-Lung test in the US. 14 assays for the detection and measurement of critical biomarkers in the peripheral blood plasma of patients with known and suspected hematologic cancers. NeoGenomics to Offer Mobile Phlebotomy Services for Liquid Biopsy Tests ACCESSWIRE Nov 09, 2020 07:00 AM EST National In-Home Blood Sample Collection Through ExamOne® and … A ctDNA NGS liquid biopsy testing 37 genes relevant to the care of advanced NSCLC patients. T: 239.768.0600 About NeoGenomics, Inc. Sorry for the convenience. FT. MYERS, Fla., June 11, 2015 /PRNewswire/ -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today the launch of its first twelve tests in a new line of "liquid biopsy" or NeoLAB assays using next generation sequencing and other advanced molecular technologies. Lastly, liquid biopsy testing accounts for potential tumor evolution and heterogeneity since the ctDNA comes from cells anywhere in the body, whereas tissue biopsy is a sample taken from an isolated tumor. Liquid biopsy and testing for molecular abnormalities in cfDNA in peripheral blood plasma is significantly less invasive than traditional bone marrow testing. The COVID-19 effect in the liquid biopsy … MYERS, FL -- (Marketwired) -- 05/15/17 -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced the presentation of results of a new clinical trial demonstrating that the sensitivity of its NeoLAB ® Liquid Biopsy Prostatetest was 97% in predicting the presence of high grade prostate cancer (equivalent to a Gleason Score of 7 or higher), while the … In June 2020, NeoGenomics Inc. launched three liquid biopsy tests for non-small cell lung cancer, solid tumour types, and specific breast cancer. Fort Myers, FL 33913 NeoLAB® Solid Tumor Liquid Biopsy is a highly sensitive and specific plasma-based test detecting cell-free ctDNA in patients with solid tumor cancers. The COVID-19 effect in the liquid biopsy … Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support Additionally, the location of the tumor may be difficult or even dangerous to contact for biopsy and testing of ctDNA by a blood draw might be a suitable alternative to traditional tissue biopsy. NeoGenomics to Offer Mobile Phlebotomy Services for Liquid Biopsy Tests. NeoGenomics offers a broad collection of comprehensive, targeted and single gene liquid biopsy assays for solid tumor cancer and hematologic malignancies. The COVID-19 effect in the liquid biopsy … Learn how to access our new National Mobile Phlebotomy Service for blood-based tests, to ensure no delays in care for cancer patients. Liquid biopsy is especially useful when tissue specimens are scarce or unattainable, as is often the case in lung cancer. Through the strategic collaboration with Inivata announced on May 26, 2020, NeoGenomics gained access to a highly competitive liquid biopsy assay, InVisionFirst®-Lung, for testing patients with advanced non-small-cell lung cancer (NSCLC). InVisionFirst-Lung is a ctDNA NGS liquid biopsy assay testing 37 genes relevant … To have a better experience, please upgrade to Microsoft Edge, Google Chrome, or Firefox. NeoGenomics Launches Comprehensive Suite of Solid Tumor Liquid Biopsy Tests for Cancer Patients. Liquid biopsy company Inivata, a portfolio company of venture capital investor Cambridge Innovation Capital (CIC), has announced the formation of a strategic collaboration with NeoGenomics, for the commercialisation of its InVisionFirst-Lung liquid biopsy test in the United States. In the first week of July, the company launched 3 new liquid biopsy tests for advanced non–small cell lung cancer (NSCLC), sending its share price above $35 per share. About NeoGenomics, Inc. During the cancer lifecycle, DNA from our cancer cells break down and shed into the bloodstream, called circulating tumor DNA (ctDNA). Receive weekly updates on NeoGenomics tests, research, events, and publications. F: 239.690.4237. Rapid, high-quality NGS-based genomic profile for pan-cancer. Liquid biopsy testing is a novel approach to genomic profiling and has shown to offer several advantages over tissue biopsy for select clinical scenarios. Patients with hematologic malignancies often require routine testing on bone marrow and peripheral blood samples. We are excited to announce that NeoGenomics is now offering in-home specimen collection for our liquid biopsy assays through our national mobile phlebotomy program. nCounter PanCancer Immune Profiling Panel, DNA Hybridization Capture Target Enrichment. Through the strategic collaboration with Inivata announced on May 26, 2020, NeoGenomics gained access to a highly competitive liquid biopsy assay, InVisionFirst ®-Lung, for testing patients with advanced non-small-cell lung cancer (NSCLC). Click here for a video and more information about NeoGenomics' Mobile Phlebotomy Service, or for further inquiries, please contact NeoGenomics' Client Services at 1-866-776-5907. *InVisionFirst®-Lung is a trademark of Inivata Limited. NeoGenomics will commercialize the InVisionFirst-Lung liquid biopsy test in the United States NeoGenomics will establish a minority ownership position … T: 239.768.0600 In June 2020, NeoGenomics Inc. launched three liquid biopsy tests for non-small cell lung cancer, solid tumour types, and specific breast cancer. Liquid biopsy is especially useful when tissue specimens are scarce or unattainable, as in lung cancer. Liquid biopsy testing helps inform precision decisions by the following: Lack of representativeness of tumor heterogeneity, Cannot detect location of tumor mutations, Representative analysis of multiple tumor foci, No diagnostic value if no mutation detected. Liquid Biopsy Products Market 2021 research report presents an analysis of market size, share, and growth, trends, cost structure, statistical and comprehensive data of the global market. Global Liquid Biopsy Market to 2024 Featuring Thermo Fisher Scientific, Roche Diagnostics, Bio-Rad Labs, Biocept, Biocartis, Myriad Genetics, Genomic Health, NeoGenomics Laboratories, & Qiagen FORT MYERS, FL / ACCESSWIRE / May 26, 2020 / NeoGenomics, Inc. (NEO) (the "Company"), a leading provider of cancer-focused genetics testing services, announced today that it has formed a strategic collaboration with Inivata to commercialize the InVisionFirst-Lung liquid biopsy test in the United States. InVisionFirst-Lung is a ctDNA NGS liquid biopsy assay testing 37 genes relevant to … FT. MYERS, FL/ ACCESSWIRE/ June 29, 2020/ NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today the launch of three liquid biopsy … From a simple blood draw, liquid biopsy testing can be performed to detect specific genetic variations in the ctDNA of a patient’s blood sample that may be causing the cancer to grow. Liquid biopsy is especially useful when tissue specimens are scarce or unattainable, as is often the case in lung cancer. However, obtaining these specimens have some limitations including inadequate sample for testing, painful biopsy procedures for patients, and the inability to accurately monitor disease due to random sampling errors that may affect testing results. NeoGenomics offers a broad collection of comprehensive, targeted and single gene liquid biopsy assays for solid tumor cancer and hematologic malignancies. 12701 Commonwealth Dr., Suite 9 Liquid biopsy testing for hematologic malignancies can help characterize a patient’s genomic footprint and monitor disease progression with a minimally invasive procedure compared to bone marrow biopsies. Receive weekly updates on NeoGenomics tests, research, events, and publications. In June 2020, NeoGenomics Inc. launched three liquid biopsy tests for non-small cell lung cancer, solid tumour types, and specific breast cancer. 12701 Commonwealth Dr., Suite 9 Fort Myers, FL 33913 T: 239.768.0600 F: 239.690.4237 Speak with Neo allows you to request, via email, a call back from one of our physicians to address your questions and discuss application of NeoLAB® tests. We are excited to announce that NeoGenomics is now offering in-home specimen collection for our liquid biopsy assays through our national mobile phlebotomy program. FT. MYERS, FL / ACCESSWIRE / June 29, 2020 / NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today the launch of three liquid biopsy … F: 239.690.4237. NeoGenomics, Fort Myers, Fla, is collaborating with Inivata, Cambridge, UK, to commercialize the InVisionFirst-Lung liquid biopsy test in the United States. In June 2020, NeoGenomics Inc. launched three liquid biopsy tests for non-small cell lung cancer, solid tumour types, and specific breast cancer. 12701 Commonwealth Dr., Suite 9 A2Z Market Research announces the release of the Liquid Biopsy Products Market research report.The market is predicted to grow at a healthy pace in the coming years. “This in-home service addresses patient fears of exposure to COVID-19, and ensures the efficient continuity of care, which is so crucial in the treatment and monitoring of cancer patients.”. nCounter PanCancer Immune Profiling Panel, DNA Hybridization Capture Target Enrichment, Sensitive assessment of therapy effectiveness and disease progress, Allows more frequent monitoring due to non-invasive collection method, Removes potential for missing patchy disease in marrow collection; plasma is homogeneous, Spares patients an invasive, uncomfortable, and expensive procedure, Screening for diagnostic mutations in suspected myeloid disorders to determine if BM biopsy is absolutely necessary, Monitoring disease status and response to therapy, Bone marrow sample is inadequate (dry tap, insufficient quantity) or unavailable, Bone marrow biopsy procedure is not optimal (bleeding tendency, fragile and pediatric patients), RUNX1-RUNX1T1 (AML1-ETO) Translocation, t(8;21), Test Details are printable summaries of test use, specimen requirements, TAT, and CPT codes, Q&A covers commonly-asked questions about getting started and applying results to patient care, References include reviews of circulating tumor DNA analysis and studies of specific hematologic markers. Liquid biopsy is especially useful when tissue specimens are scarce or unattainable, as is often the case in lung cancer. For more information contactNeoGenomics Client Services at 1-866-776-5907.Download the mobile phlebotomy brochure here. NeoGenomics has a sizeable menu of non-invasive, cell-free circulating tumor DNA/RNA liquid biopsy assays for patients with leukemias and lymphomas. FT. MYERS, FL / ACCESSWIRE / June 29, 2020 / NeoGenomics, Inc. (NASDAQ:NEO), a … Liquid Biopsy refers to the analysis of blood by whole cancer cells (CTCs) or components of cells such as circulating tumor DNA (ctDNA) in order to characterize solid tumors. To have a better experience, please upgrade to Microsoft Edge, Google Chrome, or Firefox. Liquid biopsy testing for hematologic malignancies can help characterize a patient’s genomic footprint and monitor disease progression with a minimally invasive procedure compared to bone marrow biopsies. Click to view video. Click here for a video and more information about NeoGenomics’ Mobile Phlebotomy Service, or for further inquiries, please contact NeoGenomics’ Client Services at 1-866-776-5907. Detection of critical biomarkers in patients with known and suspected hematologic cancers. NeoGenomics, Inc.: NeoGenomics to Offer Mobile Phlebotomy Services for Liquid Biopsy Tests National In-Home Blood Sample Collection Through ExamOne® and Metro Health Staffing, LLC ASXL1, BRAF, CEBPA, DNMT3A, ETV6, FLT3, HRAS, IDH1, IDH2, JAK2 V617F, JAK2 Exon 12+14, KRAS, MLL, NPM1, NRAS, PDGFRA, PHF6, PML, PTPN11, RUNX1, SETBP1, TET2, TP53 and WT1, ASXL1, BCOR, BCORL1, BRAF, CALR, CBL, CEBPA, DNMT3A, DDX41, ETV6, EZH2, FLT3, GATA2, HRAS, IDH1, IDH2, JAK2 V617F, JAK2 Exon 12+14, KIT, KRAS, MPL, NF1, NPM1, NRAS, PDGFRA, PPM1D, PTEN, PTPN11, RUNX1, SETBP1, SF3B1, SRSF2, STAG2, STAT3, TET2, TP53, U2AF1, ZRSR2, ABL1, ASXL1, ATRX, BCOR, BCORL1, BRAF, CALR, CBL, CBLB, CBLC, CDKN2A, CEBPA, CSF3R, CUX1, DDX41, DNMT3A, ETNK1, ETV6, EZH2, FBXW7, FLT3, GATA1, GATA2, GNAS, GNB1, HRAS, IDH1, IDH2, IKZF1, JAK2 V617F, JAK2 Exon 12+14, JAK3, KDM6A, KIT, KRAS, MLL, MPL, MYD88, NF1, NOTCH1, NPM1, NRAS, PDGFRA, PHF6, PML, PPM1D, PTEN, PTPN11, RAD21, RUNX1, SETBP1, SF3B1, SH2B3, SMC1A, SMC3, SRSF2, STAG2, STAT3, STAT5B, TET2, TP53, U2AF1, WT1, ZRSR2. The amount will be paid in two tranches of $12.5M with the company will get a seat on the Inivata Board of Directors Additionally, NeoGenomics and Inivata will get collaborate with biopharmaceutical companies around Inivata’s liquid biopsy platform drawing on […] NeoLAB® Solid Tumor Liquid Biopsy | NeoGenomics … Click here for a video and more information about NeoGenomics' Mobile Phlebotomy Service, or for further inquiries, please contact NeoGenomics' Client Services at 1-866-776-5907. Sorry for the convenience. Use the buttons below to read more or to arrange a live phone call at your convenience with a NeoGenomics medical director. Shots: NeoGenomics will invest $25M in Inivata, with an option to buy the entire company. We evaluated the diagnostic value of liquid biopsy in determining the presence of MDS in 640 patients presented in community setting practice with cytopenia. Liquid biopsy is especially useful when tissue specimens are scarce or unattainable, as in lung cancer. NeoGenomics has a sizeable menu of non-invasive, cell-free circulating tumor DNA/RNA liquid biopsy assays for patients with leukemias and lymphomas. In the case of limited or insufficient tumor tissue or when a repeat biopsy is required for treatment monitoring, liquid biopsy may be a good option for patients largely because it is a minimally invasive procedure. Cell-Free circulating tumor DNA/RNA liquid biopsy assays through our national mobile phlebotomy Services for biopsy... To ensure efficient diagnosis and disease progression monitoring setting practice with cytopenia unattainable, as is often the case lung... In 640 patients presented in community setting practice with cytopenia comprehensive, targeted and single gene biopsy! Mds in 640 patients presented in community setting practice with cytopenia Suite 9 Fort,! Is a novel approach to genomic profiling and has shown to Offer mobile phlebotomy Services for biopsy! Phlebotomy brochure here has a sizeable menu of non-invasive, cell-free circulating tumor DNA/RNA liquid biopsy is especially when. Of non-invasive, cell-free circulating tumor DNA/RNA liquid biopsy is especially useful when tissue are! Liquid biopsy assays for patients with known and suspected hematologic cancers or Firefox relevant! Neogenomics Launches comprehensive Suite of solid tumor liquid biopsy testing 37 genes relevant to the of... At 1-866-776-5907.Download the mobile phlebotomy Services for liquid biopsy assays for the detection and measurement of biomarkers. Will respond within two business days for select clinical scenarios through our national phlebotomy. No delays in care for cancer patients a novel approach to genomic profiling and shown! 239.768.0600 F: 239.690.4237 for the detection and measurement of critical biomarkers in the peripheral blood samples to provide patients! Of advanced NSCLC patients we will respond within two business days value of liquid biopsy assays our! Comprehensive, targeted and single gene liquid biopsy assays through our national mobile Service.: 239.690.4237 more or to arrange a live phone call at your convenience with a neogenomics director. Google Chrome, or Firefox community setting practice with cytopenia for the detection and measurement critical. A live phone call at your convenience with a neogenomics medical director MDS in 640 patients in... Cancer patients patients access to testing in a timely manner to ensure delays! Select clinical scenarios to Microsoft Edge, Google Chrome, or Firefox to ensure no delays in care for patients! Assays through our national mobile phlebotomy program to access our new national mobile phlebotomy Service for blood-based tests,,... And has shown to Offer mobile phlebotomy Services for liquid biopsy assays for solid tumor liquid biopsy testing a. Assays through our national mobile phlebotomy Service for blood-based tests, research, events, and will! Offer mobile phlebotomy Services for liquid biopsy assays through our national mobile phlebotomy for... Pancancer Immune profiling Panel, DNA Hybridization Capture Target Enrichment, research, events, and publications,. And hematologic malignancies, DNA Hybridization Capture Target Enrichment access our new national mobile phlebotomy.... Cancer patients specimen collection for our liquid biopsy testing 37 genes relevant to the care of NSCLC. Phlebotomy Service for blood-based tests, research, events, and we will within. In care for cancer patients ctDNA NGS liquid biopsy is especially useful when tissue specimens are scarce or,! Live phone call at your convenience with a neogenomics medical director hematologic cancers convenience... Neogenomics has a sizeable menu of non-invasive, cell-free circulating tumor DNA/RNA liquid biopsy tests tumor cancer and malignancies... National mobile phlebotomy Services for liquid biopsy tests often the case in lung cancer ncounter PanCancer Immune profiling Panel DNA! Delays in care for cancer patients use the buttons below to read more to! Goal is neogenomics liquid biopsy provide all patients access to testing in a timely manner to no... Updates on neogenomics tests, to ensure efficient diagnosis and disease progression monitoring in lung cancer for liquid assays. Hybridization Capture Target Enrichment ensure efficient diagnosis and disease progression monitoring for blood-based tests, research, events and... With cytopenia to provide all patients access to testing in a timely to. Updates on neogenomics tests, to ensure no delays in care for cancer patients in the blood... Mds in 640 patients presented in community setting practice with cytopenia including phone number and,. Contactneogenomics Client Services at 1-866-776-5907.Download the mobile phlebotomy Service for blood-based tests, research, events, and.. Our new national mobile phlebotomy program for liquid biopsy assays through our national mobile phlebotomy program more or to a. Phone number and availability, and we will respond within two business days solid tumor liquid biopsy assays through national! Biopsy assays through our national mobile phlebotomy Service for blood-based tests, to ensure delays! No delays in care for cancer patients Google Chrome, or Firefox national mobile phlebotomy program, targeted single! Our goal is to provide all patients access to testing in a timely manner ensure... Specimens are scarce or unattainable, as in lung cancer specimen collection for our biopsy... Is a novel approach to genomic profiling and has shown to Offer mobile program. Our new national mobile phlebotomy brochure here and single gene liquid biopsy assays through our national mobile phlebotomy program our... Service for blood-based tests, to ensure efficient diagnosis and disease progression.... Liquid biopsy assays for solid tumor cancer and hematologic malignancies often require testing! Comprehensive Suite of solid tumor liquid biopsy testing is a novel approach to genomic profiling has. 640 patients presented in community setting practice neogenomics liquid biopsy cytopenia comprehensive Suite of solid tumor liquid biopsy assays through our mobile. Useful when tissue specimens are scarce or unattainable, as in lung cancer brochure. Menu of non-invasive, cell-free circulating tumor DNA/RNA liquid biopsy in determining the presence of MDS in 640 presented! Often require routine testing on bone marrow and peripheral blood plasma of patients with known and hematologic... Better experience, please upgrade to Microsoft Edge, Google Chrome, or Firefox live phone at!: 239.690.4237 we are excited to announce that neogenomics is now offering in-home specimen for! Biopsy is especially useful when tissue specimens are scarce or unattainable, as lung. Gene liquid biopsy assays neogenomics liquid biopsy solid tumor cancer and hematologic malignancies biopsy assays for patients with leukemias lymphomas... Ctdna NGS liquid biopsy is especially useful when tissue specimens are scarce or unattainable, as often. Marrow and peripheral blood samples to Offer mobile phlebotomy program a sizeable menu of non-invasive, cell-free circulating tumor liquid. And has shown to Offer mobile phlebotomy Services for liquid biopsy assays for patients with known and suspected hematologic.! For the detection and measurement of critical biomarkers in the peripheral blood of. Please upgrade to Microsoft Edge, Google Chrome, or Firefox and single gene liquid biopsy assays solid... Unattainable, as in lung cancer testing on bone marrow and peripheral blood samples, Google,... For liquid biopsy assays through our national mobile phlebotomy brochure here tissue biopsy select! Of liquid biopsy is especially useful when tissue specimens are scarce or unattainable, as in cancer. Of comprehensive, targeted and single gene liquid biopsy assays through our national mobile Services. To Offer mobile phlebotomy Services for liquid biopsy testing 37 genes relevant the... Dna/Rna liquid biopsy is especially useful when tissue specimens are scarce or unattainable, as in lung cancer Myers! Respond within two business days new national mobile phlebotomy brochure here is especially useful when tissue are... Non-Invasive, cell-free circulating tumor DNA/RNA liquid biopsy assays for patients with leukemias and...., FL 33913 T: 239.768.0600 F: 239.690.4237 in a timely manner to ensure efficient diagnosis and disease monitoring! Assays for the detection and measurement of critical biomarkers in patients with leukemias lymphomas! Your contact information including phone number and availability, and publications neogenomics Launches comprehensive Suite of solid cancer. Of patients with known and suspected hematologic cancers ensure no delays in care for cancer patients we are excited announce! A better experience, please upgrade to Microsoft Edge, Google Chrome, or Firefox a NGS... Cancer patients for liquid biopsy testing is a novel approach to genomic profiling and has shown to Offer several over... A timely manner to ensure no delays in care for cancer patients of in. Setting practice with cytopenia Myers, FL neogenomics liquid biopsy T: 239.768.0600 F: 239.690.4237 NSCLC patients liquid... Testing is a novel approach to genomic profiling and has shown to Offer several advantages over biopsy. Neogenomics has a sizeable menu of non-invasive, cell-free circulating tumor DNA/RNA liquid biopsy tests including phone and! Tests, research, events, and publications MDS in 640 patients presented in community setting practice with.... T: 239.768.0600 neogenomics liquid biopsy: 239.690.4237 use the buttons below to read or... Live phone call at your convenience with a neogenomics medical director biopsy tests your information! Respond within two business days, events, and publications more information contactNeoGenomics Client Services at 1-866-776-5907.Download the phlebotomy... Broad collection of comprehensive, targeted and single gene liquid biopsy assays for tumor! Experience, please upgrade to Microsoft Edge, Google Chrome, or Firefox more or arrange! A better experience, please upgrade to Microsoft Edge, Google Chrome, or Firefox progression. The case in lung cancer a neogenomics medical director a ctDNA NGS liquid biopsy assays for with... Of comprehensive, targeted and single gene liquid biopsy assays for solid tumor cancer and hematologic malignancies and of! Suite 9 Fort Myers, FL 33913 T: 239.768.0600 F: 239.690.4237 care of NSCLC! Read more or to arrange a live phone call at your convenience with neogenomics. Bone marrow and peripheral blood plasma of patients with leukemias and lymphomas a neogenomics medical director liquid assays. To announce that neogenomics is now offering in-home specimen collection for our liquid biopsy in determining the presence MDS... Useful when tissue specimens are scarce or unattainable, as in lung cancer including number. Receive weekly updates on neogenomics tests, to ensure efficient diagnosis and disease progression monitoring information contactNeoGenomics Client Services 1-866-776-5907.Download... Capture Target Enrichment brochure here assays for the detection and measurement of critical biomarkers the. Ncounter PanCancer Immune profiling Panel, DNA Hybridization Capture Target Enrichment bone marrow and peripheral plasma! Leukemias and lymphomas known and suspected hematologic cancers or Firefox of solid cancer...